Results 111 to 120 of about 11,018 (185)

[Efficacy and safety of atorvastatin in major cardiovascular events: Meta-analysis]. [PDF]

Rev Med Inst Mex Seguro Soc, 2023
Villegas-Quintero VE, Rivas-Ruíz R, García-Rivero AA, Rivera-Lara P, González-Tovar NB.   +4 more
europepmc   +1 more source

¿Estatinas en Prevención Primaria? [PDF]

Revista chilena de cardiología, 2010
openaire   +2 more sources

Progressive proximal muscle weakness with subacute onset in an elderly patient: a case report. [PDF]

Rev Neurol, 2023
Martins A, Nadais G, Pinto M, Taipa R, Costa L, Pimenta S.   +5 more
europepmc   +1 more source

Achieving LDL-Cholesterol Goals: Can Implementation Science Save Us? [PDF]

Arq Bras Cardiol
Cesena FY.
europepmc   +1 more source

Cost-Effectiveness of the Use of the Coronary Calcium Score in Primary Prevention as a Guide for the Therapeutic Decision. [PDF]

Arq Bras Cardiol, 2023
Nascimento CRD, Santos JM, Mendes R, Lopes JM, Tenório PP.   +4 more
europepmc   +1 more source

Brazilian Guideline on Dyslipidemias and Prevention of Atherosclerosis - 2025. [PDF]

Arq Bras Cardiol
Rached FH, Miname MH, Rocha VZ, Zimerman A, Cesena FHY, Sposito AC, Santos RDD, Behr PEB, Bianco HT, Alves RJ, Faludi AA, Coutinho EDR, Fonseca FAH, Carvalho LSF, Bertolami A, Rocha AMD, Marte AP, Chagas ACP, Caramelli B, Polanczyk CA, Ferreira CEDS, Serrano Junior CV, Araujo DB, Moriguchi EH, Pinto FJ, Moreira HG, Back IC, Faria Neto JR, Maia KAP, Bertolami MC, Assad MHV, Izar MCO, Barreto MA, Barreto NSF, Silva PGMBE, Pimentel Filho P, Maranhão RC, Kaiser SE, Machado VA, Saraiva JFK.   +39 more
europepmc   +1 more source

Long-term mortality and predictive score performance in Brazilian atherosclerotic renovascular disease patients. [PDF]

J Bras Nefrol
Salome JG, Moraes LP, Hagemann R, Silva VDS, Carvalho FC, Franco RJDS, Vassallo D, Martin LC, Kalra PA, Barretti P.   +9 more
europepmc   +1 more source

Uso y abuso de estatinas

, 2016
La hipercolesterolemia es un factor de riesgo importante en el desarrollo de enfermedades cardiovasculares. Las estatinas siguen siendo el tratamiento de elección para la dislipidemia y la disminución del riesgo cardiovascular. Constituyen un grupo terapéutico beneficioso, seguro y económico, razones por las que su consumo se ha cuadruplicado en los ...
Suanzes Riesgo, Cristina, Suárez Diez, María Pilar, Tlemcani, Yasmine   +2 more
openaire   +1 more source

From Cholesterol Metabolism to Comprehensive Lipid Management and Crosstalk of Inflammation: Expanding the Frontiers of Cardiovascular Prevention. [PDF]

Arq Bras Cardiol
Vilela E, Bettencourt N.
europepmc   +1 more source

A gap in the prognostic score for atherosclerotic renovascular disease: the role of statins. [PDF]

J Bras Nefrol
Campos RP.
europepmc   +1 more source